2017
DOI: 10.1016/s1474-4422(17)30166-7
|View full text |Cite
|
Sign up to set email alerts
|

Safety and efficacy of dual-lead thalamic deep brain stimulation for patients with treatment-refractory multiple sclerosis tremor: a single-centre, randomised, single-blind, pilot trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
59
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 69 publications
(60 citation statements)
references
References 18 publications
0
59
1
Order By: Relevance
“…Our results also support VOP as a therapeutic target, which, either alone or in combination with VIM DBS, has shown signs of efficacy for medication-refractory tremor related to multiple sclerosis. 36 Note that this study reported comparable efficacy between VIM and VOP DBS, whereas our results would have predicted higher efficacy of VOP stimulation. However, the patients in this DBS study differed from our lesion cases in terms of diagnosis (progressive or relapsingremitting multiple sclerosis vs focal stroke), number of lesions (multiple vs single), and clinical features (any type of tremor vs Holmes tremor).…”
contrasting
confidence: 42%
See 1 more Smart Citation
“…Our results also support VOP as a therapeutic target, which, either alone or in combination with VIM DBS, has shown signs of efficacy for medication-refractory tremor related to multiple sclerosis. 36 Note that this study reported comparable efficacy between VIM and VOP DBS, whereas our results would have predicted higher efficacy of VOP stimulation. However, the patients in this DBS study differed from our lesion cases in terms of diagnosis (progressive or relapsingremitting multiple sclerosis vs focal stroke), number of lesions (multiple vs single), and clinical features (any type of tremor vs Holmes tremor).…”
contrasting
confidence: 42%
“…Our results suggest a slightly more medial GPi target could be beneficial. Our results also support VOP as a therapeutic target, which, either alone or in combination with VIM DBS, has shown signs of efficacy for medication‐refractory tremor related to multiple sclerosis . Note that this study reported comparable efficacy between VIM and VOP DBS, whereas our results would have predicted higher efficacy of VOP stimulation.…”
Section: Discussionmentioning
confidence: 99%
“…Several patients experienced AEs, encompassing MS exacerbation, seizures, intracerebral hematoma, gait/balance disturbance, asthenia and transient lower limb paresis, ataxia, dysarthria, paresthesias, and infections. Stimulation frequency ranged from 130 to 185 Hz, intensity from 0.5 to 8.0 V, and pulse width from 60 to 210 sec (Table 3)[25, 5170]. …”
Section: Resultsmentioning
confidence: 99%
“…- Multiple sclerosis-associated tremor : dual-lead thalamic DBS (one targeting the VIM border and one targeting the ventralis oralis anterior-ventralis oralis posterior border) has the highest level of clinical trial support [70], providing better control likely by stimulating the major pathways involved in MS-associated tremor, cerebello-thalamo-cortical and pallidal pathways. Almost all studies reported the use of single monopolar stimulation, with a frequency ranging from 130 to 180 Hz and variable pulse width, ranging from 60 to 210 sec, but typically higher than other tremors.…”
Section: Discussionmentioning
confidence: 99%
“…Another approach involves implantation of additional DBS electrodes, with separate or confined stimulation [11-14]. Recently, Oliveria et al [15] conducted a randomized clinical trial on dual lead thalamic stimulation in patients with refractory tremor secondary to multiple sclerosis, demonstrating an overall tremor reduction of 29.6% compared to baseline. Those patients had a second DBS electrode wire placed, allowing a potential doubling of the volume of tissue activation compared to a single DBS electrode wire.…”
Section: Introductionmentioning
confidence: 99%